Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.
作者信息
Bartlett C, Davey P, Dieppe P, Doyal L, Ebrahim S, Egger M
出版信息
Heart. 2003 Mar;89(3):327-8. doi: 10.1136/heart.89.3.327.
Abstract
摘要
相似文献
1
Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.
Heart. 2003 Mar;89(3):327-8. doi: 10.1136/heart.89.3.327.
2
The causes and effects of socio-demographic exclusions from clinical trials.
Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152. doi: 10.3310/hta9380.
3
Sex/gender disparities in randomized controlled trials of statins: the impact of awareness efforts.
Clin Invest Med. 2014 Jun 1;37(3):E163. doi: 10.25011/cim.v37i3.21383.
4
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis.
Clin Microbiol Infect. 2019 Mar;25(3):280-289. doi: 10.1016/j.cmi.2018.11.003. Epub 2018 Nov 23.
5
CORONA, statins, and heart failure: who lost the crown?
Angiology. 2008 Feb-Mar;59(1):5-8. doi: 10.1177/0003319707313882.
6
Statins for women with polycystic ovary syndrome not actively trying to conceive.
Cochrane Database Syst Rev. 2011 Oct 5(10):CD008565. doi: 10.1002/14651858.CD008565.pub2.
7
Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors.
Stroke. 1997 May;28(5):946-50. doi: 10.1161/01.str.28.5.946.
8
Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
Am Heart J. 2019 Mar;209:79-87. doi: 10.1016/j.ahj.2018.11.012. Epub 2018 Dec 20.
9
Statins.
J Obstet Gynaecol Can. 2003 Mar;25(3):231-4. doi: 10.1016/s1701-2163(16)30111-6.
10
Statins and breast cancer prevention: time for randomized controlled trials.
J Clin Oncol. 2006 May 1;24(13):2129-30; author reply 2130-1. doi: 10.1200/JCO.2005.05.5392.
引用本文的文献
1
Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions.
Pharmaceut Med. 2023 Mar;37(2):129-138. doi: 10.1007/s40290-022-00458-4. Epub 2023 Jan 18.
2
Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action.
Trials. 2021 Dec 4;22(1):880. doi: 10.1186/s13063-021-05849-7.
3
Burn model system national longitudinal database representativeness by race, ethnicity, gender, and age.
PM R. 2022 Apr;14(4):452-461. doi: 10.1002/pmrj.12618. Epub 2021 Jun 22.
4
Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity.
Contemp Clin Trials Commun. 2021 Jan 20;21:100718. doi: 10.1016/j.conctc.2021.100718. eCollection 2021 Mar.
5
Optimizing a digital intervention for managing blood pressure in stroke patients using a diverse sample: Integrating the person-based approach and patient and public involvement.
Health Expect. 2021 Apr;24(2):327-340. doi: 10.1111/hex.13173. Epub 2020 Dec 14.
6
Evaluation of Rationality of Geriatric Patients' Prescription Based On Beers Criteria in a Tertiary Care Hospital in India.
Open Access Maced J Med Sci. 2019 Mar 28;7(6):987-991. doi: 10.3889/oamjms.2019.172. eCollection 2019 Mar 30.
7
Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda.
Trials. 2014 Aug 6;15:310. doi: 10.1186/1745-6215-15-310.
8
The views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescription.
PLoS One. 2013 Aug 16;8(8):e72060. doi: 10.1371/journal.pone.0072060. eCollection 2013.
9
Statins for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004816. doi: 10.1002/14651858.CD004816.pub5.
10
Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
Drugs Aging. 2013 Apr;30(4):255-62. doi: 10.1007/s40266-013-0059-y.
本文引用的文献
1
Low prevalence of lipid lowering drug use in older men with established coronary heart disease.
Heart. 2002 Jul;88(1):25-9. doi: 10.1136/heart.88.1.25.
2
Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?
Heart. 2002 Jul;88(1):15-9. doi: 10.1136/heart.88.1.15.
3
Representation of elderly persons and women in published randomized trials of acute coronary syndromes.
JAMA. 2001 Aug 8;286(6):708-13. doi: 10.1001/jama.286.6.708.
4
Age and gender bias in statin trials.
QJM. 2001 Mar;94(3):127-32. doi: 10.1093/qjmed/94.3.127.
Zotero 插件